118 related articles for article (PubMed ID: 16759768)
1. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults.
Klein NP; Holmes TH; Sharp MA; Heineman TC; Schleiss MR; Bernstein DI; Kemble G; Arvin AM; Dekker CL
Vaccine; 2006 Aug; 24(33-34):5913-8. PubMed ID: 16759768
[TBL] [Abstract][Full Text] [Related]
2. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression.
Asanuma H; Sharp M; Maecker HT; Maino VC; Arvin AM
J Infect Dis; 2000 Mar; 181(3):859-66. PubMed ID: 10720505
[TBL] [Abstract][Full Text] [Related]
3. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
Vossen MT; Gent MR; Weel JF; de Jong MD; van Lier RA; Kuijpers TW
J Infect Dis; 2004 Jul; 190(1):72-82. PubMed ID: 15195245
[TBL] [Abstract][Full Text] [Related]
4. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
5. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
[TBL] [Abstract][Full Text] [Related]
7. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
8. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
De Castro N; Carmagnat M; Kernéis S; Scieux C; Rabian C; Molina JM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1089-97. PubMed ID: 21417759
[TBL] [Abstract][Full Text] [Related]
10. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
[TBL] [Abstract][Full Text] [Related]
11. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
[TBL] [Abstract][Full Text] [Related]
12. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
13. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
[TBL] [Abstract][Full Text] [Related]
14. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.
Okamoto S; Hata A; Sadaoka K; Yamanishi K; Mori Y
J Infect Dis; 2009 Nov; 200(10):1606-10. PubMed ID: 19821719
[TBL] [Abstract][Full Text] [Related]
15. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
16. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.
van der Heiden M; de Rond LGH; van Zelm MC; Berbers GAM; Boots AMH; Buisman AM
Front Immunol; 2018; 9():46. PubMed ID: 29410671
[TBL] [Abstract][Full Text] [Related]
17. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.
Smith JG; Levin M; Vessey R; Chan IS; Hayward AR; Liu X; Kaufhold RM; Clair J; Chalikonda I; Chan C; Bernard M; Wang WW; Keller P; Caulfield MJ
J Med Virol; 2003; 70 Suppl 1():S38-41. PubMed ID: 12627485
[TBL] [Abstract][Full Text] [Related]
18. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults.
Hayward AR; Buda K; Levin MJ
Viral Immunol; 1994; 7(1):31-6. PubMed ID: 7986334
[TBL] [Abstract][Full Text] [Related]
19. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.
Weinberg A; Lazar AA; Zerbe GO; Hayward AR; Chan IS; Vessey R; Silber JL; MacGregor RR; Chan K; Gershon AA; Levin MJ
J Infect Dis; 2010 Apr; 201(7):1024-30. PubMed ID: 20170376
[TBL] [Abstract][Full Text] [Related]
20. Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function.
Landmeier S; Altvater B; Pscherer S; Eing BR; Kuehn J; Rooney CM; Juergens H; Rossig C
Cancer Res; 2007 Sep; 67(17):8335-43. PubMed ID: 17804749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]